Human papillomavirus vaccination and Pap testing profile in Manitoba, Canada

被引:8
作者
Kliewer, Erich V. [1 ,2 ,3 ]
Mahmud, Salaheddin M. [1 ,2 ]
Demers, Alain A. [1 ,2 ]
Lambert, Pascal [1 ]
机构
[1] CancerCare Manitoba, Epidemiol & Canc Registry, Winnipeg, MB, Canada
[2] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada
[3] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
关键词
Human papillomavirus (HPV); Vaccination; Screening; Pap test; Cervical cancer; CERVICAL-CANCER; HPV VACCINATION; (HPV)ASSOCIATED CANCERS; YOUNG-WOMEN; HEALTH; IMMUNOGENICITY; INEQUALITIES; EFFICACY; VACCINES; SUCCESS;
D O I
10.1016/j.vaccine.2013.10.082
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Females who receive the human papillomavirus (HPV) vaccine may believe they are protected from developing cervical cancer and no longer require screening. Concern has also been expressed that vaccinated females are those that would be screened regularly. This study assesses the Pap testing behavior of vaccinated and non-vaccinated females. Methods: For this population-based retrospective cohort study, vaccination and screening registries were linked for 3540 vaccinated females aged 15 years and over and 9592 matched non-vaccinated females. Conditional logistic regression, the Kaplan-Meier method and Cox regression were used to examine the association between vaccination and Pap testing. Results: Vaccinated females were more likely to have had a Pap test within the year prior to the index date than non-vaccinated females (15-19 years old: OR = 1.38,95% CI 1.20-1.59; 20+ years old: OR = 2.34, 95% CI 1.98-2.76). In the three-year period after the index date, vaccinated females had a significantly higher cumulative probability of having a Pap test (83.3%) than non-vaccinated females (66.1%). Females who had a Pap test within three years prior to the index date were more likely to have a Pap test after the index date (vaccinated: HR = 5.03, 95% CI 4.65-5.45; non-vaccinated HR = 3.97, 95% CI 3.70-4.24). Being vaccinated had a significant effect on Pap testing (15-19 years old: HR = 1.54, 95% CI 1.39-1.69; 20+ years old: HR = 1.87,95% CI 1.52-2.31). 80.1% of vaccinated females who had a Pap test prior to the index date also had one subsequent to it, compared to 70.1% for non-vaccinated females. 41.1% of females had not been vaccinated nor had a Pap test. Conclusion: The majority of vaccinated females continue to participate in screening, and do so at a higher rate than non-vaccinated females. Renewed efforts need to be made to include the large proportion of non-vaccinated, non-screened females in vaccination and/or screening. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:33 / 38
页数:6
相关论文
共 31 条
[1]   Human papilloma virus (HPV) prophylactic vaccination: Challenges for public health and implications for screening [J].
Adams, M. ;
Jasani, B. ;
Fiander, A. .
VACCINE, 2007, 25 (16) :3007-3013
[2]   Risk Factors for Incident Condyloma in a Multinational Cohort of Men: The HIM Study [J].
Anic, Gabriella M. ;
Lee, Ji-Hyun ;
Villa, Luisa L. ;
Lazcano-Ponce, Eduardo ;
Gage, Christine ;
Silva, Roberto Jose C. ;
Baggio, Maria L. ;
Quiterio, Manuel ;
Salmeron, Jorge ;
Papenfuss, Mary R. ;
Abrahamsen, Martha ;
Stockwell, Heather ;
Rollison, Dana E. ;
Wu, Yougui ;
Giuliano, Anna R. .
JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (05) :789-793
[3]   Inequalities in Human Papillomavirus (HPV)Associated Cancers: Implications for the Success of HPV Vaccination [J].
Brisson, Marc ;
Drolet, Melanie ;
Malagon, Talia .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (03) :158-161
[4]   Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia [J].
Brotherton, Julia M. L. ;
Mullins, Robyn M. .
CANCER EPIDEMIOLOGY, 2012, 36 (03) :298-302
[5]   Correlates for Human Papillomavirus Vaccination of Adolescent Girls and Young Women in a Managed Care Organization [J].
Chao, Chun ;
Velicer, Christine ;
Slezak, Jeff M. ;
Jacobsen, Steven J. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 (03) :357-367
[6]   How well do the theory of reasoned action and theory of planned behaviour predict intentions and attendance at screening programmes? A meta-analysis [J].
Cooke, Richard ;
French, David P. .
PSYCHOLOGY & HEALTH, 2008, 23 (07) :745-765
[7]   Sociodemographic Inequalities in Sexual Activity and Cervical Cancer Screening: Implications for the Success of Human Papillomavirus Vaccination [J].
Drolet, Melanie ;
Boily, Marie-Claude ;
Greenaway, Christina ;
Deeks, Shelley L. ;
Blanchette, Caty ;
Laprise, Jean-Francois ;
Brisson, Marc .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (04) :641-652
[8]   Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years [J].
Einstein, Mark H. ;
Baron, Mira ;
Levin, Myron J. ;
Chatterjee, Archana ;
Fox, Bradley ;
Scholar, Sofia ;
Rosen, Jeffrey ;
Chakhtoura, Nahida ;
Lebacq, Marie ;
van der Most, Robbert ;
Moris, Philippe ;
Giannini, Sandra L. ;
Schuind, Anne ;
Datta, Sanjoy K. ;
Descamps, Dominique .
HUMAN VACCINES, 2011, 7 (12) :1359-1373
[9]   Cervical cancer screening following prophylactic human papillomavirus vaccination [J].
Franco, Eduardo L. ;
Cuzick, Jack .
VACCINE, 2008, 26 :A16-A23
[10]   Issues in planning cervical cancer screening in the era of HPV vaccination [J].
Franco, Eduardo L. ;
Cuzick, Jack ;
Hildesheim, Allan ;
de Sanjose, Silvia .
VACCINE, 2006, 24 :171-177